Jagsonpal Pharmaceuticals Limited — Important, 05-02-2025: Updates

Changes in key management personnel (KMPs) have been approved following the appointment of Mr. Sachin Jain as Chief Financial Officer. The Board of Directors has updated the authorized representatives for determining the materiality of events and information required for disclosures to stock exchanges. The primary contacts are Mr. Manish Gupta, Managing Director, and Mr. Sachin Jain, CFO, along with Mr. Abhishek Joshi, Company Secretary. This development points towards a streamlined approach in compliance and governance, potentially enhancing operational efficiency. Investors should watch closely as these changes may positively influence the company's strategic direction.